An HER3-targeting antibody–drug conjugate incorporating a DNA topoisomerase I inhibitor U3-1402 conquers EGFR tyrosine kinase inhibitor-resistant NSCLC
暂无分享,去创建一个
K. Nishio | K. Nakagawa | Y. Chiba | K. Yonesaka | K. Sakai | T. Kagari | H. Kawakami | K. Haratani | N. Maeda | N. Takegawa | K. Hirotani | Satomi Watanabe | S. Watanabe